FDA RECALL ALERT

Cefazolin in Dextrose Injection 2g/100mL

Baxter recalls Cefazolin in Dextrose Injection 2g/100mL over particulate matter (cardboard) in solution.

What to do

Consumers and healthcare providers should immediately check inventory for Lot LD175708, EXP 14-Feb-2027. Stop using affected bags and contact Baxter at (888) 229-0001 for return and replacement instructions.

Posted

2026-07-24

Agency

FDA

Firm

BAXTER

Status

ONGOING

Why it was recalled

Baxter is recalling Cefazolin in Dextrose Injection, USP, 2g/100mL single-dose infusion bags due to particulate matter (cardboard) found in the solution. Administration of the affected product may cause adverse events including local irritation, phlebitis, or allergic reaction.

Is mine affected?

Check the lot code and best-by (or expiration) date printed on your package. Yours is affected if it matches one below.

2G3508

Lot code: LD175708
Best-by: 14-Feb-2027
NDC: 0338-3508-41

Official source

View on U.S. Food and Drug Administration →

Editorial summary by Recall Canary · last updated 2026-07-24 · primary source: U.S. Food and Drug Administration